Taken together, we were not able to reveal a clear co-occurence/mutual exclusivity pattern for ARID1A and TP53/RB1 genetic alterations in bladder carcinoma samples (S5 Fig and S3 Table). This evidence concerns the gene RB1 and urinary bladder carcinoma.